Craniosynostosis and multiple skeletal anomalies in humans and zebrafish result from a defect in the localized degradation of retinoic acid.

Standard

Craniosynostosis and multiple skeletal anomalies in humans and zebrafish result from a defect in the localized degradation of retinoic acid. / Laue, Kathrin; Pogoda, Hans-Martin; Daniel, Philip B; van Haeringen, Arie; Alanay, Yasemin; von Ameln, Simon; Rachwalski, Martin; Morgan, Tim; Gray, Mary J; Breuning, Martijn H; Sawyer, Gregory M; Sutherland-Smith, Andrew J; Nikkels, Peter G; Kubisch, Christian; Bloch, Wilhelm; Wollnik, Bernd; Hammerschmidt, Matthias; Robertson, Stephen P.

In: AM J HUM GENET, Vol. 89, No. 5, 5, 2011, p. 595-606.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Laue, K, Pogoda, H-M, Daniel, PB, van Haeringen, A, Alanay, Y, von Ameln, S, Rachwalski, M, Morgan, T, Gray, MJ, Breuning, MH, Sawyer, GM, Sutherland-Smith, AJ, Nikkels, PG, Kubisch, C, Bloch, W, Wollnik, B, Hammerschmidt, M & Robertson, SP 2011, 'Craniosynostosis and multiple skeletal anomalies in humans and zebrafish result from a defect in the localized degradation of retinoic acid.', AM J HUM GENET, vol. 89, no. 5, 5, pp. 595-606. <http://www.ncbi.nlm.nih.gov/pubmed/22019272?dopt=Citation>

APA

Laue, K., Pogoda, H-M., Daniel, P. B., van Haeringen, A., Alanay, Y., von Ameln, S., Rachwalski, M., Morgan, T., Gray, M. J., Breuning, M. H., Sawyer, G. M., Sutherland-Smith, A. J., Nikkels, P. G., Kubisch, C., Bloch, W., Wollnik, B., Hammerschmidt, M., & Robertson, S. P. (2011). Craniosynostosis and multiple skeletal anomalies in humans and zebrafish result from a defect in the localized degradation of retinoic acid. AM J HUM GENET, 89(5), 595-606. [5]. http://www.ncbi.nlm.nih.gov/pubmed/22019272?dopt=Citation

Vancouver

Bibtex

@article{a9b98ae1025345508681f382d7f795d8,
title = "Craniosynostosis and multiple skeletal anomalies in humans and zebrafish result from a defect in the localized degradation of retinoic acid.",
abstract = "Excess exogenous retinoic acid (RA) has been well documented to have teratogenic effects in the limb and craniofacial skeleton. Malformations that have been observed in this context include craniosynostosis, a common developmental defect of the skull that occurs in 1 in 2500 individuals and results from premature fusion of the cranial sutures. Despite these observations, a physiological role for RA during suture formation has not been demonstrated. Here, we present evidence that genetically based alterations in RA signaling interfere with human development. We have identified human null and hypomorphic mutations in the gene encoding the RA-degrading enzyme CYP26B1 that lead to skeletal and craniofacial anomalies, including fusions of long bones, calvarial bone hypoplasia, and craniosynostosis. Analyses of murine embryos exposed to a chemical inhibitor of Cyp26 enzymes and zebrafish lines with mutations in cyp26b1 suggest that the endochondral bone fusions are due to unrestricted chondrogenesis at the presumptive sites of joint formation within cartilaginous templates, whereas craniosynostosis is induced by a defect in osteoblastic differentiation. Ultrastructural analysis, in situ expression studies, and in vitro quantitative RT-PCR experiments of cellular markers of osseous differentiation indicate that the most likely cause for these phenomena is aberrant osteoblast-osteocyte transitioning. This work reveals a physiological role for RA in partitioning skeletal elements and in the maintenance of cranial suture patency.",
keywords = "Animals, Humans, Female, Disease Models, Animal, Mice, Gene Expression Regulation, Developmental, Sequence Homology, Amino Acid, Cell Differentiation, Pregnancy, Osteogenesis/drug effects/genetics, Polymorphism, Genetic/genetics, *Cranial Sutures/drug effects/embryology/growth & development/pathology, *Craniosynostoses/enzymology/genetics/pathology, *Cytochrome P-450 Enzyme System/antagonists & inhibitors/genetics, Fetal Death/genetics, Growth and Development/genetics, Osteoblasts/cytology, *Tretinoin/metabolism/pharmacology, Zebrafish/embryology/genetics, Zebrafish Proteins/*genetics, Animals, Humans, Female, Disease Models, Animal, Mice, Gene Expression Regulation, Developmental, Sequence Homology, Amino Acid, Cell Differentiation, Pregnancy, Osteogenesis/drug effects/genetics, Polymorphism, Genetic/genetics, *Cranial Sutures/drug effects/embryology/growth & development/pathology, *Craniosynostoses/enzymology/genetics/pathology, *Cytochrome P-450 Enzyme System/antagonists & inhibitors/genetics, Fetal Death/genetics, Growth and Development/genetics, Osteoblasts/cytology, *Tretinoin/metabolism/pharmacology, Zebrafish/embryology/genetics, Zebrafish Proteins/*genetics",
author = "Kathrin Laue and Hans-Martin Pogoda and Daniel, {Philip B} and {van Haeringen}, Arie and Yasemin Alanay and {von Ameln}, Simon and Martin Rachwalski and Tim Morgan and Gray, {Mary J} and Breuning, {Martijn H} and Sawyer, {Gregory M} and Sutherland-Smith, {Andrew J} and Nikkels, {Peter G} and Christian Kubisch and Wilhelm Bloch and Bernd Wollnik and Matthias Hammerschmidt and Robertson, {Stephen P}",
year = "2011",
language = "English",
volume = "89",
pages = "595--606",
journal = "AM J HUM GENET",
issn = "0002-9297",
publisher = "Cell Press",
number = "5",

}

RIS

TY - JOUR

T1 - Craniosynostosis and multiple skeletal anomalies in humans and zebrafish result from a defect in the localized degradation of retinoic acid.

AU - Laue, Kathrin

AU - Pogoda, Hans-Martin

AU - Daniel, Philip B

AU - van Haeringen, Arie

AU - Alanay, Yasemin

AU - von Ameln, Simon

AU - Rachwalski, Martin

AU - Morgan, Tim

AU - Gray, Mary J

AU - Breuning, Martijn H

AU - Sawyer, Gregory M

AU - Sutherland-Smith, Andrew J

AU - Nikkels, Peter G

AU - Kubisch, Christian

AU - Bloch, Wilhelm

AU - Wollnik, Bernd

AU - Hammerschmidt, Matthias

AU - Robertson, Stephen P

PY - 2011

Y1 - 2011

N2 - Excess exogenous retinoic acid (RA) has been well documented to have teratogenic effects in the limb and craniofacial skeleton. Malformations that have been observed in this context include craniosynostosis, a common developmental defect of the skull that occurs in 1 in 2500 individuals and results from premature fusion of the cranial sutures. Despite these observations, a physiological role for RA during suture formation has not been demonstrated. Here, we present evidence that genetically based alterations in RA signaling interfere with human development. We have identified human null and hypomorphic mutations in the gene encoding the RA-degrading enzyme CYP26B1 that lead to skeletal and craniofacial anomalies, including fusions of long bones, calvarial bone hypoplasia, and craniosynostosis. Analyses of murine embryos exposed to a chemical inhibitor of Cyp26 enzymes and zebrafish lines with mutations in cyp26b1 suggest that the endochondral bone fusions are due to unrestricted chondrogenesis at the presumptive sites of joint formation within cartilaginous templates, whereas craniosynostosis is induced by a defect in osteoblastic differentiation. Ultrastructural analysis, in situ expression studies, and in vitro quantitative RT-PCR experiments of cellular markers of osseous differentiation indicate that the most likely cause for these phenomena is aberrant osteoblast-osteocyte transitioning. This work reveals a physiological role for RA in partitioning skeletal elements and in the maintenance of cranial suture patency.

AB - Excess exogenous retinoic acid (RA) has been well documented to have teratogenic effects in the limb and craniofacial skeleton. Malformations that have been observed in this context include craniosynostosis, a common developmental defect of the skull that occurs in 1 in 2500 individuals and results from premature fusion of the cranial sutures. Despite these observations, a physiological role for RA during suture formation has not been demonstrated. Here, we present evidence that genetically based alterations in RA signaling interfere with human development. We have identified human null and hypomorphic mutations in the gene encoding the RA-degrading enzyme CYP26B1 that lead to skeletal and craniofacial anomalies, including fusions of long bones, calvarial bone hypoplasia, and craniosynostosis. Analyses of murine embryos exposed to a chemical inhibitor of Cyp26 enzymes and zebrafish lines with mutations in cyp26b1 suggest that the endochondral bone fusions are due to unrestricted chondrogenesis at the presumptive sites of joint formation within cartilaginous templates, whereas craniosynostosis is induced by a defect in osteoblastic differentiation. Ultrastructural analysis, in situ expression studies, and in vitro quantitative RT-PCR experiments of cellular markers of osseous differentiation indicate that the most likely cause for these phenomena is aberrant osteoblast-osteocyte transitioning. This work reveals a physiological role for RA in partitioning skeletal elements and in the maintenance of cranial suture patency.

KW - Animals

KW - Humans

KW - Female

KW - Disease Models, Animal

KW - Mice

KW - Gene Expression Regulation, Developmental

KW - Sequence Homology, Amino Acid

KW - Cell Differentiation

KW - Pregnancy

KW - Osteogenesis/drug effects/genetics

KW - Polymorphism, Genetic/genetics

KW - Cranial Sutures/drug effects/embryology/growth & development/pathology

KW - Craniosynostoses/enzymology/genetics/pathology

KW - Cytochrome P-450 Enzyme System/antagonists & inhibitors/genetics

KW - Fetal Death/genetics

KW - Growth and Development/genetics

KW - Osteoblasts/cytology

KW - Tretinoin/metabolism/pharmacology

KW - Zebrafish/embryology/genetics

KW - Zebrafish Proteins/genetics

KW - Animals

KW - Humans

KW - Female

KW - Disease Models, Animal

KW - Mice

KW - Gene Expression Regulation, Developmental

KW - Sequence Homology, Amino Acid

KW - Cell Differentiation

KW - Pregnancy

KW - Osteogenesis/drug effects/genetics

KW - Polymorphism, Genetic/genetics

KW - Cranial Sutures/drug effects/embryology/growth & development/pathology

KW - Craniosynostoses/enzymology/genetics/pathology

KW - Cytochrome P-450 Enzyme System/antagonists & inhibitors/genetics

KW - Fetal Death/genetics

KW - Growth and Development/genetics

KW - Osteoblasts/cytology

KW - Tretinoin/metabolism/pharmacology

KW - Zebrafish/embryology/genetics

KW - Zebrafish Proteins/genetics

M3 - SCORING: Journal article

VL - 89

SP - 595

EP - 606

JO - AM J HUM GENET

JF - AM J HUM GENET

SN - 0002-9297

IS - 5

M1 - 5

ER -